Sister-chromatid exchanges and chromosal breakage in patients treated with cytostatics.
The frequency of structural chromosomal rearrangements and sister-chromatid exchanges (SCEs) was investigated in short-term phytohemagglutininstimulated lymphocyte cultures by means of bromodeoxyuridine substitution and fluorescence plus Giemsa (FPG) staining technique. Both these parameters were significantly increased in patients treated with comparatively low doses of cyclophosphamide, busulphan and adriamycin. The increased SCE rate was proportional to the number of chromosome breaks, the ratio of SCE to breaks being about 100:1. The increase in the SCE number was maintained for several months after the termination of cytostatic therapy, when the conventional analysis of chromosome breaks yielded normal results. Normal SCE values were obtained in two patients treated with low doses of fluorouracil.
D001973:Bromodeoxyuridine; D002066:Busulfan / Q000627:therapeutic use*; D002842:Chromatids / Q000187:drug effects*; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D004317:Doxorubicin; D003520:Cyclophosphamide; D002066:Busulfan; D001973:Bromodeoxyuridine; D005472:Fluorouracil